News from Tuesday, September 12, 2023
Articles
Beneficiaries with Cancer Spend Less Out-of-Pocket in Medicare Advantage
(9/12, Victoria Bailey, Health Payer Intelligence) reports “Medicare Advantage beneficiaries with cancer experienced lower out-of-pocket costs and had access to more benefits than those in Medicare fee-for-service (FFS), research conducted by ATI Advisory and commissioned by the Better Medicare Alliance found...Specifically, those with Medicare Advantage spent $3,996, while those with FFS spent $6,091, for a difference of $2,095.” Full
The Evolution of Precision Medicine in Pharmacy
(9/11, Rayn Oswalt, Pharmacy Times) comments “...[P]recision medicine holds immense promise in revolutionizing the field of pharmacy and transforming patient care. By leveraging patient-specific genetic, environmental, and lifestyle information, pharmacists can tailor drug selection, dosing, and treatment monitoring to optimize outcomes and minimize [adverse effects]. As technology and research progress, the future prospects for precision medicine are bright, with expanded genetic markers, increased availability of pharmacogenomic testing, and personalized treatments for rare diseases on the horizon. However, challenges related to data privacy, cost, and patient awareness must be addressed to realize the full potential of precision medicine.” Full
Japan Takes New Steps To Build On Real-World Data Foundations
(9/11, Lisa Takagi, Pink Sheet) reports “...As Japan widens its window for the use of real-world data to support drug development though revision of the Next Generation Medical Infrastructure Act, the pharma industry is hoping for more regular inclusion in regulatory filings. A dedicated group within the PMDA shares its views on how the area is developing and practical measures being taken to drive RWD adoption.” Subscription Required
Press Releases
PCORI's Board of Governors Approves 34 New Members to Multi-Stakeholder Advisory Panels
(9/12, PCORI Press Release) “...‘Members of our advisory panels bring perspectives vital to PCORI’s mission, and we eagerly anticipate the contributions that this new and distinguished set of colleagues brings to our work,’ said Harv Feldman, M.D., MSCE, PCORI’s deputy executive director for patient-centered research programs. ‘The wide range of stakeholder voices represented within these panels will greatly benefit our efforts to achieve the ambitious goal that PCORI has set forth: to fund comparative clinical effectiveness research to improve patients’ health and clinical outcomes.’” Full
Peterson Health Technology Institute Releases New Digital Health Assessment Framework
(9/12, Peterson Health Technology Institute Press Release) “...The ICER-PHTI Assessment Framework for Digital Health Technologies was developed in partnership with the Institute for Clinical and Economic Research...PHTI’s independent assessments will evaluate the performance of health technologies designed to replace or augment traditional care delivery, including digital therapeutics, chronic care management apps, remote patient monitoring, and administrative technologies, many of which include artificial intelligence. The assessment framework will prioritize products’ clinical benefits and economic impact, as well as their effects on health equity, privacy, and security.” Full
Walgreens and Pearl Health Announce Strategic Partnership to Advance Value-Based Care Delivery
(9/12, Walgreens Press Release) “...Pearl Health offers technology and insight solutions that empower clinical teams to provide holistic, personalized treatment necessary for value-based, quality-focused care. Walgreens will provide complementary services, including prescription fulfillment, medication adherence, immunizations, care gap closure and diagnostic testing. Walgreens will also work with providers to help patients discharged from the hospital transition to home.” Full
Journals
Improving Food and Drug Administration–Centers for Medicare and Medicaid Services Coordination for Drugs Granted Accelerated Approval
Peter J. Neumann, Elliott Crummer, James D. Chambers, Sean R. Tunis
August 31, 2023, The Milbank Quarterly
A Centralized EHR-Based Model for the Recruitment of Rural and Lower Socioeconomic Participants in Pragmatic Trials: A Secondary Analysis of the Diuretic Comparison Project
Cynthia Hau, et al.
September 5, 2023, JAMA Network Open
Use of SGLT2i and ARNi in Patients with Atrial Fibrillation and Heart Failure in 2021-2022: An Analysis of Real-World Data
Alvaro Alonso, et al.
September 10, 2023, medRxiv
The Stiff Joint: Comparative Evaluation of Monotherapy and Combination Therapy With Urate Lowering Agents in Managing Acute Gout
Okelue E. Okobi, et al.
September 12, 2023, Cureus
Real-World Data: Applications and Relevance to Cancer Clinical Trials
Andrew J Gross, et al.
October 2023, Seminars in Radiation Oncology
Reports
Medicare Advantage Has Unique Ability to Meet Needs of Cancer Patients and Survivors
September 7, 2023